PROXY STATEMENT/PROSPECTUS
MERGER PROPOSED — YOUR VOTE IS VERY IMPORTANT
September 7, 2021
To the Stockholders of Capstead Mortgage Corporation:
The board of directors (the “BSPRT Board”) of Benefit Street Partners Realty Trust, Inc. (“BSPRT”) and the board of directors (the “Capstead Board”) of Capstead Mortgage Corporation (“Capstead”), each a Maryland corporation, each have approved an Agreement and Plan of Merger, dated as of July 25, 2021 (as such agreement may be amended or modified from time to time, the “Merger Agreement”), by and among BSPRT, Rodeo Sub I, LLC, a Maryland limited liability company (“Merger Sub”), Capstead and Benefit Street Partners L.L.C., a Delaware limited liability company and the external advisor of BSPRT (the “BSPRT Advisor”) pursuant to which Capstead will merge with and into Merger Sub, with Merger Sub continuing as the surviving company (the “Merger”). The closing of the Merger will occur as promptly as practicable following satisfaction of all closing conditions set forth in the Merger Agreement, but either BSPRT or Capstead may terminate the Merger Agreement if the closing has not occurred by January 26, 2022. Upon completion of the Merger, BSPRT will change its name to “Franklin BSP Realty Trust, Inc.” and its shares of Class A common stock, par value $0.01 per share (“BSPRT Common Stock”), will be listed on the New York Stock Exchange under the symbol “FBRT”.
Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.01 per share, of Capstead (“Capstead Common Stock”) will be converted into the right to receive: from BSPRT, (A) a number of shares of BSPRT Common Stock equal to the quotient (rounded to the nearest one ten-thousandth) (the “Exchange Ratio”) determined by dividing (i) Capstead’s adjusted book value per share by (ii) BSPRT’s adjusted book value per share (the “Per Share Stock Consideration”), and (B) a cash amount equal to the product of (rounding to the nearest cent) (x) Capstead’s adjusted book value per share multiplied by 15.75%, multiplied by (y) 22.5%, without any interest thereon (the “Per Share Cash Consideration” and together with the Per Share Stock Consideration, the “Per Common Share BSPRT Consideration”); and from the BSPRT Advisor, a cash amount equal to the product of (rounding to the nearest cent) (A) Capstead’s adjusted book value per share multiplied by 15.75%, multiplied by (B) 77.5%, without any interest thereon (the “Advisor Cash Consideration” and together with the Per Common Share BSPRT Consideration, the “Total Per Common Share Consideration”).
Based on the number of shares of Capstead Common Stock and the number of Company performance units outstanding on the close of business on August 3, 2021, and an assumed Exchange Ratio of 0.3521 based on the adjusted book value per share of BSPRT Common Stock and Capstead Common Stock as of June 30, 2021, calculated in accordance with the Merger Agreement, we expect approximately 34,344,313 shares of BSPRT Common Stock will be issued in connection with the Merger. The actual Exchange Ratio will be publicly announced at least three business days before the Capstead special meeting of stockholders as described below.
Each share of Capstead’s 7.50% Series E Cumulative Redeemable Preferred Stock, $0.10 par value per share, will be converted into the right to receive one share of a newly designated series of BSPRT preferred stock, par value $0.01 per share, which will be classified and designated as BSPRT’s 7.50% Series E Cumulative Redeemable Preferred Stock (“BSPRT Series E Preferred Stock”), which will be listed on the New York Stock Exchange under the symbol “FBRT PRE” upon completion of the Merger.
Capstead will hold a special meeting of its stockholders, which will be held solely by means of remote communication live over the Internet on October 15, 2021, at 9:00 a.m., Central Time. Holders of Capstead Series E Preferred Stock will not be entitled to vote on any matter at the Capstead special meeting.
At the Capstead special meeting, the Capstead common stockholders will be asked to (i) consider and vote on a proposal (the “Capstead Merger Proposal”) to approve the Merger and the other transactions contemplated by the Merger Agreement, (ii) consider and vote on a non-binding advisory proposal (the “Capstead Non-Binding Compensation Advisory Proposal”) to approve the compensation that may be paid or become payable to Capstead’s named executive officers that is based on or otherwise relates to the Merger and (iii) approve the adjournment of the Capstead special meeting, if necessary or appropriate, for the purpose of soliciting additional votes for the approval of the Capstead Merger Proposal (the “Capstead Adjournment Proposal”). The Capstead Board has unanimously (i) determined that the Merger Agreement and the transactions contemplated thereby, including the Merger, are in the best interests of Capstead, (ii) approved the Merger Agreement and declared that the transactions contemplated by the Merger Agreement, including the Merger, are advisable, (iii) directed that the Merger and the other transactions contemplated by the Merger Agreement be submitted to the holders of Capstead Common Stock for consideration at the Capstead special meeting and (iv) recommended, in accordance with and subject to the provisions of the Merger Agreement, that the holders of Capstead Common Stock approve the Merger and the other transactions contemplated by the Merger Agreement. The Capstead Board unanimously recommends that the Capstead common stockholders vote “FOR” the Capstead Merger Proposal, “FOR” the Capstead Non-Binding Compensation Advisory Proposal and “FOR” the Capstead Adjournment Proposal. Only those matters included in the notice of the Capstead special meeting (“Notice of Special Meeting”) may be considered and voted upon at the Capstead special meeting.
This proxy statement/prospectus provides detailed information about the Capstead special meeting, the Merger Agreement, the Merger and other related matters. A copy of the Merger Agreement is included as Annex A to this proxy statement/prospectus. We encourage you to read this proxy statement/prospectus, the Merger Agreement and the other annexes to this proxy statement/prospectus carefully and in their entirety.
In particular, you should carefully consider the discussion in the section of this proxy statement/prospectus entitled “Risk Factors” beginning on page 26. You may also obtain more information about each company from the documents they file with the Securities and Exchange Commission (the “SEC”).
Whether or not you plan to attend the Capstead special meeting virtually, please complete, date, sign and return, as promptly as possible, the enclosed proxy card in the accompanying reply envelope or authorize a proxy to vote your shares of Capstead Common Stock through the Internet or by telephone. You may also authorize a proxy to vote your shares over the Internet using the Internet address on the enclosed proxy card or by telephone using the toll-free number on the enclosed proxy card. If you authorize a proxy to vote your shares through the Internet or by telephone, you will be asked to provide the company number and control number from the enclosed proxy card. If you attend and vote at a special meeting virtually over the Internet, your vote by ballot will revoke any proxy previously submitted.
Your vote is very important, regardless of the number of shares of Capstead Common Stock you own. Whether or not you plan to attend the Capstead special meeting virtually, please authorize a proxy to vote your shares of stock as promptly as possible to make sure that your shares of stock are represented at the special meeting. Please note that the failure to vote, or authorize a proxy to vote, your shares of stock of Capstead is the equivalent of a vote against the Capstead Merger Proposal.
Thank you in advance for your continued support.
Sincerely,
Phillip A. Reinsch
President, Chief Executive Officer and Director
Capstead Mortgage Corporation
Neither the SEC nor any state securities regulatory agency has approved or disapproved of the securities to be issued in connection with the Merger or passed upon the adequacy or accuracy of this proxy statement/prospectus. Any representation to the contrary is a criminal offense.
This proxy statement/prospectus is dated September 7, 2021, and is first being mailed to the stockholders of Capstead on or about September 8, 2021.